Last reviewed · How we verify

NCT05394038: My-ABCDE

Rapid Diagnosis of Patients With Chest Pain During the Covid-19 Outbreak (My-ABCDE)

Completed Last updated 27 May 2022
What this trial tests

trial testing None,observational study. in Chest Pain in 2,218 participants. Completed in 20 May 2022.

Timeline
1 May 2022
Primary endpoint
20 May 2022
20 May 2022

Quick facts

Lead sponsorShanghai 10th People's Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment2,218
Start date1 May 2022
Primary completion20 May 2022
Estimated completion20 May 2022
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Shanghai 10th People's Hospital

Who can join

14 and older, any sex, with Chest Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

During the outbreak of COVID-19, among patients with chest tightness and chest pain as the main symptoms in major medical institutions in Shanghai, China, the past medical history and rapid testing were used to quickly identify the risk stratification of the patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chest Pain

Currently open trials in the same condition.

Other Shanghai 10th People's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05394038.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing